jennifer doudna

  • Bio
    China sides with Emmanulle Charpentier and Jennifer Doudna in CRISPR patent war

    China sides with Emmanulle Charpentier and Jennifer Doudna in CRISPR patent war

    Continuing the patent dispute internationally, China has now given the Charpentier/Doudna side a patent to edit genes in the country. CRISPR pioneers Emmanuelle Charpentier and Jennifer Doudna lost a patent case to the Broad Insititute earlier this year when the court determined the Broad Insititute had an application markedly different than Charpentier’s and Doudna’s overall patent. Read More

  • CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW

    CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW

    Jennifer Doudna, co-inventor of CRISPR Cas9 technology, or the ability to program genes using a special enzyme, spoke about the promises of this technology onstage at SXSW this afternoon. In a keynote today, Doudna noted that while this technology is very young (less than five years old), “it’s been deployed very rapidly for existing applications.” Read More

  • Bio
    CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans

    CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans

    The decision of who owned the rights to a hotly disputed CRISPR gene editing patent came down in favor of the Broad Institute of MIT and Harvard today so you’d think the mood would be sour at the University of California, Berkeley, the other contender in the case. But Berkeley’s Jennifer Doudna tells TechCrunch this is a positive for her. “I’m actually delighted to know… Read More

  • Bio
    Oral arguments for who owns CRISPR-Cas9 start next month

    Oral arguments for who owns CRISPR-Cas9 start next month

    The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9. Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institute Emmanuelle Charpentier head to court on December 6th to face off against MIT’s Feng Zhang and present their argument before three US Patent and Trademark Office judges on why… Read More

  • Bio
    CRISPR loses Nobel to tiny machines

    CRISPR loses Nobel to tiny machines

    CRISPR, the gene-editing technology revolutionizing the biotech industry, has failed to take home the Nobel prize in chemistry for the second year in a row. Instead, the award went to Jean-Pierre Sauvage, J. Fraser Stoddart, and Bernard L. Feringa – three men who developed the world’s smallest machines using molecular physics. Each will share equally in the 8 million Swedish kronor… Read More

  • Bio
    Jennifer Doudna, inventor of gene editing technology CRISPR Cas9, is coming to Disrupt

    Jennifer Doudna, inventor of gene editing technology CRISPR Cas9, is coming to Disrupt

    Berkeley professor of chemistry and molecular and cell biology and the inventor of the revolutionary CRISPR Cas9 gene editing technology Jennifer Doudna is going to join us for the first time on our Disrupt stage in SF this September. We’ll chat with Doudna about her discovery of a tool called Cas9 that not only is upending the biotech industry but could have a domino effect on… Read More